Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

IgM

Product Sizes
1 mg
16-16-090713-M-1MG
5 mg
16-16-090713-M-5MG
10 mg
16-16-090713-M-10MG
About this Product
SKU:
16-16-090713-M
Additional Names:
Complement System, In Vitro Diagnostics, Infection, Glycoproteomics, Biotherapeutics, Anaphylaxis, Rheumatoid Arthritis, Autoimmune Diseases, Wiskott-Aldrich syndrome|IgM Myeloma
Buffer:
Frozen in 50 mM Tris-HCl, pH 8.0, with 200 mM NaCl and 0.05% NaN3
CE/IVD:
RUO
Extra Details:
Serum IgM is a pentameric or hexameric macro-immunoglobulin that serves as the first-line defense in humoral immunity. Constituting 1.2-4.0 mg/mL in plasma, it features 10-12 antigen-binding sites, enabling high-avidity interactions with pathogens, particularly non-protein antigens like microbial carbohydrates and lipids. As the earliest antibody produced during infection and the primary immunoglobulin in neonates, IgM activates the classical complement pathway through C1 binding, promoting opsonization and pathogen lysis. Its inability to cross the placenta makes elevated neonatal IgM a marker for intrauterine infections. IgM plays dual roles in autoimmune pathology. While natural IgM aids homeostasis by clearing cellular debris, autoreactive IgM drives diseases like cold agglutinin disease and idiopathic thrombocytopenic purpura through erythrocyte or platelet targeting4. Deficiencies manifest in Wiskott-Aldrich syndrome (linked to thrombocytopenia and recurrent infections) and Hyper IgM syndromes, characterized by impaired class-switching and susceptibility to Pneumocystis pneumonia, cryptosporidiosis, and malignancies. Clinically, IgM serves diagnostic and therapeutic purposes. It indicates recent infections through serological testing and helps identify autoimmune conditions via autoantibody detection. Intravenous immunoglobulin (IVIG) preparations containing IgM are used for immune thrombocytopenic purpura and Guillain-Barre syndrome, leveraging IgM's immunomodulatory properties.
Formulation:
Frozen in 50 mM Tris-HCl, pH 8.0, with 200 mM NaCl and 0.05% NaN3
Molecular Weight:
950,000 Da
Physical State:
Frozen
Purity:
≥95%
Purification:
Liquid Chromatography Methods
Shipping Conditions:
Dry Ice
Source:
Source human myeloma plasma non-reactive for HBsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.
Storage Conditions:
Please refer to datasheet
Supplier:
Athens Research & Technology Inc.
Type:
Antibody: Isotype Controls